A rare disease is any disease that affects a small percentage of the population. The extremely low incidence rate of rare diseases makes it particularly difficult to recognize and diagnose them. A major challenge in the rare disease market is how to target physicians who are potentially involved...

The goal of this research is to jointly study physician prescription decisions and patient drug request behaviors. We have adopted a binary logit model and a multinomial logit (MNL) model to study patient drug request data with excessive zero requests and a MNL model to capture physician...

Pharmaceutical firms continue to advertise more and more prescription drugs directly to consumers, advocating them to discuss the focal health condition and the efficacy of the advertised drug with their physicians. In this paper, we investigate the effectiveness of such direct-to-consumer...

This study analyzes the effect of DTCA expenditures for anti-hyperlipidemia drugs on patient behaviors. The key findings are: (a) DTCA expenditures have a positive and long-term effect on the number of visits to physicians by newly-diagnosed hyperlipidemia patients. (b) The effectiveness of DTCA...